Pneumococcal vaccination rates in children with sickle cell disease

Journal of Public Health Management and Practice

Volumn 20, Issue 6, 2014, Pages 587-590

  Nero, Alecia C ^a   Akuete, Kwei ^b   Reeves, Sarah Leasure ^c   Dombkowski, Kevin J ^d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Maryland Inpatient Care Specialist   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Invasive pneumococcal disease; Pneumococcal vaccine; Sickle cell disease

Indexed keywords

PNEUMOCOCCUS VACCINE;

CASE CONTROL STUDY; CHILD; CHILD HEALTH CARE; COHORT ANALYSIS; COMPARATIVE STUDY; COMPLICATION; FEMALE; HUMAN; IMMUNIZATION; INFANT; MALE; MEDICAID; MICHIGAN; NEWBORN; PNEUMOCOCCAL INFECTIONS; PRESCHOOL CHILD; SICKLE CELL ANEMIA; STATISTICS AND NUMERICAL DATA; UNITED STATES; VACCINATION;

ANEMIA, SICKLE CELL; CASE-CONTROL STUDIES; CHILD; CHILD HEALTH SERVICES; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; MALE; MEDICAID; MICHIGAN; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; UNITED STATES; VACCINATION;

EID: 84918805176     PISSN: 10784659     EISSN: 15505022     Source Type: Journal    
DOI: 10.1097/PHH.0000000000000034     Document Type: Article

References (19)

1. Hassell KL. Population estimates of sickle cell disease in the U. S. Am J Prev Med. 2010;38(4S):S512-S521.
2. Serjeant GR, Serjeant BE. Sickle Cell Disease. 3rd ed. New York, NY: Oxford University Press; 2001.
3. Wong WY, Overturf GD, Powars DR. Infection caused by Streptococcus pneumonia in children with sickle cell disease: epidemiology, immunologic mechanisms, prophylaxis, and vaccination. Clin Infect Dis. 1992;14(5):1124-1136.
4. Leikin SL, Gallagher D, Kinney TR, et al. Mortality in children and adolescents with sickle cell disease. Cooperative study of sickle cell disease. Pediatrics. 1989;84(3):500-508.
5. Adamkiewicz TV, Sarnaik S, Buchanan GR, et al. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr. 2003;143:438-444.
6. McCavit TL, Xuan L, Zhang S, et al. Hospitalization for invasive pneumococcal disease in a national sample of children with sickle cell disease before and after PCV7 licensure. Pediatr Blood Cancer. 2012;58:945-949.
7. Centers for Disease Control and Prevention. Manual for the Surveillance of Vaccine-Preventable Diseases, 5th ed. Atlanta, GA: Centers for Disease Control and Prevention; 2008: chap 11.
8. World Health Organization. Pneumococcal vaccines: World Health Organization position paper. WHO Wkly Epidemiol Rec. 1999;74 (23) 150-151.
9. American Academy of Pediatrics. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Chicago, IL: American Academy of Pediatrics; 2009.
10. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 12th ed. Washington, DC: Public Health Foundation; 2011.
11. Ellison AM, Ota KV, McGowan KL, et al. Pneumococcal bacteremia in a vaccinated pediatric sickle cell disease population. Pediatr Infect Dis J. 2012;31:534-536.
12. American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for the prevention of Streptococcus pneumoniae in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23). Pediatrics. 2010;126(1):186-190.
13. Halasa NB, Shankar SM, Talbot TR, et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2007;44:1428-1433.
14. McCavit TL, Quinn CT, Techasaensiri C, Rogers ZR. Increase in invasive Streptococcus pneumonia infections in children with sickle cell disease since pneumococcal conjugate vaccine licensure. J Pediatr. 2011;158:505-507.
15. Centers for Disease Control and Prevention. National Immunization Survey Tables. http://www.cdc.gov/vaccines/stats-surv/nis/data/tables 2008.htm. Accessed February 4, 2011.
16. Santoli JM, Peter G, Arvin AM, et al. Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee. JAMA. 2003;290(23):3122-3128.
17. Centers for Disease Control and Prevention. Updated recommendations on the use of pneumococcal conjugate vaccine: suspension of recommendation for third and fourth dose. MMWR Morb Mortal Wkly Rep. 2004;53(8):177-178.
18. Vernacchio L, Neufeld EJ, MacDonald K, et al. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. J Pediatr. 1998;133:275-278.
19. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986;314:1593-1599.